TB

The Latent TB Infection (LTBI) Treatment Fact Sheet Series is designed to complement patient education delivered by healthcare professionals. For each of the three CDC-recommended LTBI regimens, there is a fact sheet in the series that can be personalized for individual patients. Each sheet provides patients with a written reminder of their treatment regimen, medication side effects, actions to take if side effects do occur, tips to help remain adherent to the medication, and instructions in the event a dose of medication is missed.

This fact sheet describes the impact of HIV-TB co-infection. It also presents work currently being done to find and treat HIV-TB.

Based on The Union's 93-years of working in the field, the new guide tackles the challenges of fulfilling each patient's potential for cure from both the clinician's and the programme manager's perspective.

The Tuberculosis Drug Information Guide, 2nd edition, is derived from Drug-Resistant Tuberculosis: A Survival Guide for Clinicians (2nd edition) produced in 2008. Two additional drugs, ofloxacin and clarithromycin (which are used primarily outside of the US), have been included. This Guide can help any physician, nurse, or pharmacist who participates in the management of patients with TB or LTBI.

This interim guidance provides advice on the inclusion of bedaquiline in the combination therapy of MDR-TB in accordance with the existing WHO Guidelines for the Programmatic Management of Drug-resistant TB (2011 Update).

This fact sheet provides basic information about TB.

This document sets out basic principles for prioritizing risk groups and choosing a screening approach. It emphasizes the importance of assessing the epidemiological situation, adapting approaches to local situations, integrating TB screening into other health-promotion activities, minimizing the risk of harm to individuals, and engaging in continual monitoring and evaluation.

This brochure provides basic information for patients about the TB blood test.

The recommendations in this manual are based on assessments of the risks associated with different technical procedures performed in different types of TB laboratories. The manual describes the basic requirements for facilities and practices, which can be adapted to follow local or national regulations or as the result of a risk assessment.

This guide provides information and guidance on TB integration in HIV programming. It is meant to be a hands-on tool that organizations can use to plan and implement effective TB activities in their communities.